$197.42
0.510.26%
At close: -
$197.42
00.00%
After Hours: Nov 29, 1:00 PM EDT
Krystal Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Krystal Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $0.91 | $0.90 | 1.11 % |
Jun 2024 | 2024-08-05 | $0.94 | $0.62 | 51.6 % |
Mar 2024 | 2024-05-06 | $0.46 | $0.15 | 206.7 % |
Dec 2023 | 2024-02-26 | $0.30 | $-0.37 | 181.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $83.84M | $82.94M | 1.09 % |
Jun 2024 | 2024-08-05 | $70.28M | $64.43M | 9.09 % |
Mar 2024 | 2024-05-06 | $45.25M | $47.42M | -4.58 % |
Dec 2023 | 2024-02-26 | $42.14M | $28.61M | 47.3 % |
Krystal Biotech (KRYS) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $0.91, which beat the estimate of $0.90.
The Actual Revenue was $83.8M, which beat the estimate of $82.9M.
Browse earnings estimates, EPS, and revenue on all stocks.